期刊文献+

罗哌卡因与舒芬太尼混合液用于臂丛神经阻滞麻醉的观察 被引量:9

Clinical Observation of Mixture Solution of Ropivacaine and Sufentanil in Brachial Plexus Nerve Block Anesthesia
下载PDF
导出
摘要 目的探讨甲磺酸罗哌卡因与舒芬太尼混合液用于臂丛神经阻滞麻醉在上肢手术中应用的可行性与安全性。方法择期行上肢手术患者100例,术前ASAⅠ~Ⅱ级,随机双盲法分为试验组与对照组,试验组50例用0.894%甲磺酸罗哌卡因15 mL+舒芬太尼10μg(1 mL)+0.9%氯化钠注射液14 mL制成30 mL混合药液A。对照组50例用0.894%甲磺酸罗哌卡因15 mL+0.9%氯化钠注射液15mL制成30 mL混合药液B,对比观察麻醉后生命体征及镇痛、镇静、麻醉效果评分,比较心电图、动脉血氧饱和度、平均动脉压、心率等指标。结果两组患者注药后各时间点平均动脉压、心率、动脉血氧饱和度的差异无统计学意义(P>0.05)。在麻醉后10 min试验组疼痛评分明显低于对照组,麻醉起效较快。试验组患者在注药后20 min镇静效果明显优于对照组,差异有统计学意义(P<0.05)。麻醉效果方面,试验组优良率96.00%,而对照组86.00%,两组比较有显著性差异(P<0.01)。两组麻醉过程中均未出现不良反应。结论在行臂丛神经阻滞麻醉时,用罗哌卡因复合舒芬太尼比单用罗哌卡因镇痛作用起效快、时间长、镇静作用好,可减少镇静催眠药物的用量,降低不良反应发生率,是一种安全、有效的神经阻滞方法。 Objective To explore the feasibility and safety of mixture solution of ropivacaine mesylate with sufentanil for brachial plexus nerve block anesthesia used in the upper extremity surgery. Methods 100 cases of elective upper extremity surgery with ASA Ⅰ- Ⅱ level were divided into the experimental group and control group by the random double-blind method. The experimental group (50 eases) was given 30 mL of the mixture solution A prepared by 0. 894% ropivacaine mesylate 15 mL plus sufentanil 10μg (1 mL) plus O. 9% sodium chloride injection 14 mL. The control group (50 cases) was given 30 mL of the mixture solution B prepared by 0. 894% ropivacaine mesylate 15 mL plus 0.9% sodium chloride injection 15 mL. The vital signs, scores of analgesic, sedative and anesthetic effects after anesthesia were observed and compared between the two groups. Moreover, the changes of ECG, SPO2, MAP, HR, and other indicators after anesthesia were compared. Results The differences in MAP, HR, SPO: at different timepoints between the two groups had no statistical significance (P〉0. 05). The pain score at 10 min after anesthesia in the experimental group was significantly lower than that in the control group, anesthesia effect was faster. The sedative effect at 20 rain after drug administration in the experi-mental group was obviously superior to that in the control group, the difference was statistically significant (P 〈0. 05). In the anesthesia effect, the excellent and good rate was 96.00% in the experimental group and 86.00% in the control group with statistically significant differences between the two groups (P 〈0. 01 ). Two groups all did not appear adverse reactions during anesthesia. Conclusion In con-ducting brachial plexus nerve block anesthesia, the combination use of ropivacaine mesylate and sufentanil has fast onset time of analge-sia, long analgesic time and good sedative effect than pure ropivacaine mesylate, can reduce sedative-hypnotic drug dosage and the oc-currence rate of adverse reactions, which is a safe and effective method of nerve block.
出处 《中国药业》 CAS 2013年第15期22-23,共2页 China Pharmaceuticals
关键词 甲磺酸罗哌卡因 舒芬太尼 臂丛神经阻滞麻醉 上肢手术 ropivacaine mesylate sufentanil brachial plexus nerve block anesthesia upper extremity surgery
  • 相关文献

参考文献6

  • 1郭曲练,姚尚龙.临床麻醉学[M].第3版.北京:人民卫生出版社,2011,8:128-129,337.
  • 2郭艳辉,王俊科,许国忠,虞建刚.罗哌卡因用于蛛网膜下腔阻滞的实验研究[J].中华麻醉学杂志,2002,22(1):42-45. 被引量:155
  • 3Zhang ZX, Jiang XH. The laboratory study of ropivacaine mesylate [J ]. The Master' s Degree Article of Sichuan University,2002(4): 16 - 19.
  • 4Wood MB, Rubin AP. A comparison of epidural 1% ropivacaine and 0.75% bupivacaine for lower abdominal gynecologic surgery[J]. Anesth Analg, 1993,76: 1 274.
  • 5张志祥,蒋学华.甲磺酸罗哌卡因注射剂实验研究[D].成都:四川大学,2002.
  • 6胡双飞,钱军,严蔚.舒芬太尼用于高血压病人肺切除术后镇痛的效应[J].中华麻醉学杂志,2005,25(11):855-856. 被引量:31

二级参考文献15

  • 1刘忠渊,张富春,赵干,钟哲,王宾.手术应激反应的新概念——神经免疫内分泌学说[J].国外医学(麻醉学与复苏分册),1995,16(4):193-195. 被引量:84
  • 2Svensson LG, Klepp P, Hinder RA. Spinal cord anatomy of the baboon: comparison with man and implications of spinal cord blood flow during thoracic aortic cross-clamping, A Aft J Surg, 1986, 24:32-34.
  • 3Krause GS, White BC, Aust SD, et al. Brain cell death following ischmia and reperfusion: a proposed biochemical sequence. Crit Care Med, 1988,16:714-726.
  • 4Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates on spinal cord function after temporary thoracic aortic occlusion. J Neurosci, 1984, 4:1884-1891.
  • 5Coombs DW. Management of chronic pain by epidural and intrathecal opioids: Newer drugs and delivery systems. Int Anesthesiol Clin, 1983, 24:59-74.
  • 6Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine, 1985, 10: 777-781.
  • 7Ishizake M, Sugiyama S, Uehida H, et al. Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med Okeyama 1997, 51: 71-77.
  • 8Kroin JS, McCarthy, Kerns JM, et al. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology, 1987,66: 737-742.
  • 9Grosby G. Local spinal cord blood flow and glucose utilization during spinal anesthesia with bupivacaine infusion in dogs. Anesthesiology,1987, 63: 55-60.
  • 10Kristensen JD. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg,1996, 82:636-640.

共引文献186

同被引文献43

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部